# Efficacy and Safety Study of Xyotax to Treat Prostate Cancer

> **NCT00446836** · PHASE2 · COMPLETED · sponsor: **The Methodist Hospital Research Institute** · enrollment: 29 (actual)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **DRUG:** Paclitaxel polyglumex (Xyotax)

## Key facts

- **NCT ID:** NCT00446836
- **Lead sponsor:** The Methodist Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2007-11
- **Final completion:** 2008-01
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2016-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00446836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00446836, "Efficacy and Safety Study of Xyotax to Treat Prostate Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00446836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*